SCHEMBL1014861

SCHEMBL1014861

Nc1cccc(Cc2ccco2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
CYP19A1 P11511 1/20 0.44
POLB P06746 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
GPR52 Q9Y2T5 1/20 0.39
CYP3A4 P08684 1/20 0.39
CASP1 P29466 1/20 0.39
RECQL P46063 1/20 0.39
TSHR P16473 1/20 0.39
PARP1 P09874 1/20 0.38
ADORA2A P29274 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14774870 0.79 MEN1 (0.54) MAOAMAOBPOLBMEN1KMT2A
SCHEMBL2797369 0.78 TAAR1 (0.44) MAOBPOLBMEN1KMT2APTGS1
SCHEMBL2264958 0.78 HPGD (0.48) POLBNPC1GAAMEN1KMT2A
SCHEMBL49433 0.77 MAOB (0.62) MAOAMAOBCYP19A1CA1CA2
SCHEMBL30583096 0.77 MAOB (0.62) MAOAMAOBCYP19A1CA1CA2
SCHEMBL20869665 0.76 KMT2A (0.61) MEN1KMT2AALDH1A1
SCHEMBL596315 0.76 CALM1 (0.50) POLBMEN1KMT2APTGS1PTGS2
Hydrochloric Acid SCHEMBL10936113 0.75 MAOB (0.64) MAOAMAOBCYP19A1CA1CA2
SCHEMBL9719335 0.75 MAOB (0.60) MAOAMAOBCYP19A1CA1CA2
Hydrochloric Acid SCHEMBL8644377 0.75 MAOB (0.64) MAOAMAOBCYP19A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 MAOA 378/4885MAOB 565/4885CYP19A1 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.